ENTA has never reached the highest (20%) royalty tier, but they did reach the second-highest (17%) tier in 2018 and 2019.
As shown in the schedule in #msg-142808661, reaching the highest royalty tier would require ABBV's HCV sales in a given calendar year to exceed $5B ($2.5B/0.50), which is not gonna happen.
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.